| Does hyperglycemia affect the diagnostic value of (18)F-FDG PET/CT? | |
| | |
MedLine Citation:
|
PMID: 22088805 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: Net cellular uptake of (18)F-FDG is adversely affected by elevated plasma glucose levels. The purpose of our study was to investigate the influence of hyperglycemic state at the time of (18)F-FDG injection on the diagnostic accuracy of (18)F-FDG PET/CT. METHOD: Pre-scan plasma glucose levels of all patients who were referred for PET/CT with an oncologic indication during the year 2005 were reviewed. All seventy-six patients (50 men, 26 women, mean age±SD: 65.5±9.7 years) with pre-scan glucose level higher than 140mg/dL (mean plasma glucose level±SD: 168.7±30.8, ranging from 140 to 260mg/dL) were enrolled into our study. The accuracy of PET/CT scans was assessed using concurrent or follow-up CT, MRI and histologic evidences as well as clinical follow-up as the reference standard. RESULTS: PET/CT was true positive in 37 patients, true-negative in 30 patients, false negative in 6 patients and false positive in 3 patients. Overall sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy of (18)F-FDG PET/CT on a patient basis were 86%, 90.9%, 92.5%, 83.3% and 88.1%, respectively. Diabetes mellitus was recorded in 50 patients. No significant diagnostic accuracy difference between diabetics and non-diabetics was noticed. CONCLUSION: Our study suggests that (18)F-FDG accumulation of malignant lesions remains sufficiently high for reliable qualitative clinical diagnosis in chronic and acute hyperglycemic states. However, regarding the discordant and inconclusive results of the available reports and the remarkable concerns with reference to the adverse effects of elevated plasma glucose levels on the diagnostic accuracy of (18)F-FDG PET/CT scans, further direct clues seems to be required and should be provided by future studies. |
| | |
Authors:
|
S Mirpour; P Meteesatien; A H Khandani |
Related Documents
:
|
22033725 - Quality control in neuroradiology: discrepancies in image interpretation among academic... 21719455 - Coronary ct angiographic characteristics of culprit lesions in acute coronary syndromes... 11685625 - Intracranial image-guided neurosurgery: experience with a new electromagnetic navigatio... 6383705 - An overview of ct based stereotactic systems for the localization of intracranial lesions. 21529795 - Sixteen cases of pulmonary sclerosing haemangioma: ct findings are not definitive for p... 10699735 - Methods: mrt. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-11-14 |
Journal Detail:
|
Title: Revista espanola de medicina nuclear Volume: - ISSN: 0212-6982 ISO Abbreviation: - Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-11-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9208726 Medline TA: Rev Esp Med Nucl Country: - |
Other Details:
|
Languages: ENG; SPA Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 Elsevier España, S.L. and SEMNIM. All rights reserved. |
Affiliation:
|
Division of Nuclear Medicine, Department of Radiology, University of North Carolina, School of Medicine, NC, United States; Research Institute for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Quality of Life and Experience of Care in Women With Metastatic Breast Cancer: A Cross-Sectional Sur...
Next Document: Associations between CYP1A1 and CYP2E1 polymorphisms and susceptibility to esophageal cancer in Chao...